US clearance for Dormio Tech's sleep diagnostic device
This article was originally published in Clinica
Dormio Tech's FloChannel system for diagnosing obstructive sleep apnoea and other sleep disorders has received 510(k) clearance from the US FDA. The Chatsworth, California company, a subsidiary of Chad Therapeutics, claims it is the only device that independently monitors left and right nasal airflow. This means the system can detect nasal cycling – the periodic alternation in airflow resistance between the two nasal cavities – as well as oral airflow and snoring. FloChannel connects easily to standard sleep lab systems, Dormio Tech says. Chad plans to begin shipping the device by September.